Application of the Plan-Do-Check-Action Cycle in Reducing the Incidence of Forearm Hematoma in Patients After Transradial Artery Percutaneous Coronary Interventions

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Background

Transradial puncture has the advantages of significantly fewer complications, less patient pain, shorter hospital stays, and reduced hospital costs, but it tends to cause forearm hematoma, so reducing the rate of forearm hematoma is imperative. This study assessed the value of the plan–do–check–act (PDCA) cycle in standardizing nursing management in reduce the incidence of forearm hematoma in patients after transradial artery Percotaneous Coronary Intervention(PCI).

Methods

This study was conducted on 260 patients with acute myocardial infarction admitted to our hospital between January 2022 and June 2022 who underwent coronary intervention. The subjects were divided into control-group (n=130) and observation-group (n=130) in accordance with their admission time. The control-group received routine nursing care; and the observation-group, was applied with PDCA nursing management in addition to conventional treatment.

Results

The incidence of forearm hematoma in patients after radial artery PCI decreased from 24.62% to 8.46% (P < 0.05).

Conclusion

The PDCA cycle management model was effective in reducing the incidence of forearm hematoma without increasing adverse patient outcomes.

Related collections

Most cited references 13

Record: found
Abstract: not found
Article: not found

Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association

Emelia Benjamin, Salim S. Virani, Clifton Callaway … (2018)

0 comments Cited 1628 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies

Iosif Xenogiannis, Marco A Zenati, Deepak Bhatt … (2021)

Saphenous vein grafts (SVGs) remain the most frequently used conduits in coronary artery bypass graft surgery (CABG). Despite advances in surgical techniques and pharmacotherapy, SVG failure rates remain high, often leading to repeat coronary revascularization. The no-touch SVG harvesting technique (minimal graft manipulation with preservation of vasa vasorum and nerves) reduces the risk of SVG failure, whereas the effect of the off-pump technique on SVG patency remains unclear. Use of buffered storage solutions, intraoperative graft flow measurement, careful selection of the target vessels, and physiological assessment of the native coronary circulation before CABG may also reduce the incidence of SVG failure. Perioperative aspirin and high-intensity statin administration are the cornerstones of secondary prevention after CABG. Dual antiplatelet therapy is recommended for off-pump CABG and in patients with a recent acute coronary syndrome. Intermediate (30%–60%) SVG stenoses often progress rapidly. Stenting of intermediate SVG stenoses failed to improve outcomes; hence, treatment focuses on strict control of coronary artery disease risk factors. Redo CABG is associated with higher perioperative mortality compared with percutaneous coronary intervention (PCI); hence, the latter is preferred for most patients requiring repeat revascularization after CABG. SVG PCI is limited by high rates of no-reflow and a high incidence of restenosis during follow-up. Drug-eluting and bare metal stents provide similar long-term outcomes in SVG PCI. Embolic protection devices reduce no-reflow and should be used when feasible. PCI of the corresponding native coronary artery is associated with better short- and long-term outcomes and is preferred over SVG PCI, if technically feasible.

0 comments Cited 53 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: found

Is Open Access

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022

Yukio Ozaki, Hironori Hara, Yoshinobu Onuma … (2022)

Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Interventional and Therapeutics (CVIT) society proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018. Updated guidelines for the management of AMI were published by the European Society of Cardiology (ESC) in 2017 and 2020. Major changes in the guidelines for STEMI patients included: (1) radial access and drug-eluting stents (DES) over bare-metal stents (BMS) were recommended as a Class I indication, (2) complete revascularization before hospital discharge (either immediate or staged) is now considered as Class IIa recommendation. In 2020, updated guidelines for Non-ST-Elevation Myocardial Infarction (NSTEMI) patients, the followings were changed: (1) an early invasive strategy within 24 h is recommended in patients with NSTEMI as a Class I indication, (2) complete revascularization in NSTEMI patients without cardiogenic shock is considered as Class IIa recommendation, and (3) in patients with atrial fibrillation following a short period of triple antithrombotic therapy, dual antithrombotic therapy (e.g., DOAC and single oral antiplatelet agent preferably clopidogrel) is recommended, with discontinuation of the antiplatelet agent after 6 to 12 months. Furthermore, an aspirin-free strategy after PCI has been investigated in several trials those have started to show the safety and efficacy. The Task Force on Primary PCI of the CVIT group has now proposed the updated expert consensus document for the management of AMI focusing on procedural aspects of primary PCI in 2022 version.

0 comments Cited 49 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Journal

Journal ID (nlm-ta): J Multidiscip Healthc

Journal ID (iso-abbrev): J Multidiscip Healthc

Journal ID (publisher-id): jmdh

Title: Journal of Multidisciplinary Healthcare

Publisher: Dove

ISSN (Electronic): 1178-2390

Publication date (Electronic): 26 February 2025

Publication date Collection: 2025

Volume: 18

Pages: 1183-1189

Affiliations

[1 ]Department of Cardiology, Jinhu County People’s Hospital , Huaian City, People’s Republic of China

Author notes

Correspondence: Xiaoyan Zhou, Department of Cardiology, Jinhu County People’s Hospital , Jiangsu Province, Huaian City, People’s Republic of China, Tel: +86 18015198693, Fax +86 51786808708, Email jsjhcardiology@163.com

Article

Publisher ID: 511825

DOI: 10.2147/JMDH.S511825

PMC ID: 11873013

PubMed ID: 40035030

SO-VID: 8a9f85fd-8474-4617-9f28-2a1b20e56c68

License:

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

History

Date received : 17 December 2024

Date accepted : 18 February 2025

Page count

Figures: 2, Tables: 2, References: 13, Pages: 7

Funding

Funded by: funding to report;

There is no funding to report.

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Most referenced authors 459

See all reference authors

Application of the Plan-Do-Check-Action Cycle in Reducing the Incidence of Forearm Hematoma in Patients After Transradial Artery Percutaneous Coronary Interventions

Read this article at

Abstract

Background

Methods

Results

Conclusion

Related collections

Karger: Nephrology

Most cited references 13

Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association

Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022

Author and article information

Journal

Affiliations

Author notes

Article

History

Page count

Funding

Categories

Comments

Comment on this article

Similar content 706

Most referenced authors 459